Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Werfen is a privately held specialized diagnostics company focused on in vitro diagnostic systems, reagents, software, and related services for hospitals and clinical laboratories. The company is a worldwide leader in hemostasis, acute care diagnostics, transfusion, autoimmunity, and transplant diagnostics, and also operates an OEM business that develops and manufactures customized assays and biomaterials. Founded in Barcelona in 1966, Werfen operates globally through direct operations and distributors, with technology centers in the United States and Europe. Its portfolio is primarily commercial-stage rather than therapeutics-focused, serving laboratory medicine and hospital diagnostics rather than drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wefern Life.